Literature DB >> 2254953

Microtubule associated protein (MAP1B) is present in cultured oligodendrocytes and co-localizes with tubulin.

I Fischer1, J Konola, E Cochary.   

Abstract

Differentiation of oligodendrocytes is accompanied by the extension of processes and the assembly of the myelin membrane. It is likely that the cytoskeleton plays an important role in this process in terms of changes in cell shape, transport of myelin components, and organization of the myelin membrane. Oligodendrocytes contain microtubules (MT) which associate with other components of the cytoskeleton, and microtubule associated proteins (MAPs) may mediate some of these interactions. In this study we have shown the presence of MAP1B in oligodendrocytes grown in primary glial cultures by double-label immunofluorescence using antibodies to galactocerebroside (GC) and MAP1B. The staining of the cultures showed that GC-positive oligodendrocytes were also stained with MAP1B antibodies. However, MAP1B stain was limited to cell bodies and processes, whereas GC stain was also seen in flattened membrane sheets and punctate staining in processes. MAP1B staining was also compared with that of myelin proteolipid (PLP), myelin basic protein (MBP) and beta-tubulin in secondary glial cultures that were enriched for oligodendrocytes. The results showed a typical staining of cell bodies and membranous profiles using PLP antibodies, and the staining of cell bodies and flattened regions of membranous sheets by MBP antibodies. In contrast, both polyclonal and monoclonal antibodies to MAP1B showed a uniform diffuse staining of cell bodies, major processes, and fine interconnected processes. Double-labeling of the cells showed that MAP1B was co-localized with tubulin, but was not present in glial fibrillary acidic protein (GFAP)-positive astrocytes. Western and Northern blot analyses of primary glial cultures showed that MAP1B had a molecular mass of 320 kDa and a mRNA of 10 kb. These values are identical to those previously reported for brain MAP1B (Safaei and Fischer, 1989) and demonstrate the presence of MAP1B in oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254953     DOI: 10.1002/jnr.490270117

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

Review 1.  The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.

Authors:  Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007-12-04       Impact factor: 3.444

Review 2.  Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration.

Authors:  J Nunez; I Fischer
Journal:  J Mol Neurosci       Date:  1997-06       Impact factor: 3.444

3.  The cytoskeletal components of the myelin fraction are affected by a single intracranial injection of apotransferrin in young rats.

Authors:  O E Cabrera; G Bongiovanni; M Hallak; E F Soto; J M Pasquini
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

4.  QKI binds MAP1B mRNA and enhances MAP1B expression during oligodendrocyte development.

Authors:  Lixia Zhao; Li Ku; Yuntao Chen; Mingjing Xia; Patrizia LoPresti; Yue Feng
Journal:  Mol Biol Cell       Date:  2006-07-19       Impact factor: 4.138

5.  Identification of novel mRNAs expressed in oligodendrocytes.

Authors:  H Baba; B Fuss; J B Watson; L T Zane; W B Macklin
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

6.  Immunohistochemical studies on the new type of astrocytic inclusions identified in a patient with brain malformation.

Authors:  S Kato; A Hirano; T Umahara; F Herz; K Shioda; M Minagawa
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Human myelin proteome and comparative analysis with mouse myelin.

Authors:  Akihiro Ishii; Ranjan Dutta; Greg M Wark; Sun-Il Hwang; David K Han; Bruce D Trapp; Steven E Pfeiffer; Rashmi Bansal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

Review 8.  Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.

Authors:  C A Dyer
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

9.  Essential function, sophisticated regulation and pathological impact of the selective RNA-binding protein QKI in CNS myelin development.

Authors:  Katrina Bockbrader; Yue Feng
Journal:  Future Neurol       Date:  2008-11

10.  The light chains of microtubule-associated proteins MAP1A and MAP1B interact with α1-syntrophin in the central and peripheral nervous system.

Authors:  Heike Fuhrmann-Stroissnigg; Rainer Noiges; Luise Descovich; Irmgard Fischer; Douglas E Albrecht; Fatiha Nothias; Stanley C Froehner; Friedrich Propst
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.